Track topics on Twitter Track topics that are important to you
Recapitalization of the Company in Partnership with Senior Management Team will Provide Capital for Future Growth
Petsky Prunier is pleased to announce it has advised Medical Knowledge Group, LLC, an analytics-driven and technology-enabled, multi-channel healthcare marketing and communications provider servicing the biopharmaceutical industry, on its recapitalization led by MTS Health Investors, LLC. Medical Knowledge Group’s existing senior management team will maintain a significant minority ownership position and has partnered with MTS to recapitalize the business and to obtain additional capital to support future growth. Medical Knowledge Group was previously a portfolio company of private equity firm, CIVC Partners.
Medical Knowledge Group’s analytics and technology-enabled multi-channel marketing solutions support marketing, medical affairs, and stakeholder relations teams at biopharmaceutical companies throughout the entire product lifecycle. The Company has an exceptional reputation for translating complex science into highly effective market shaping strategies through the integration of their marketing and medical expertise with sophisticated data analytics capabilities and its diverse roster of clients range from niche biotech and diagnostic companies to some of the world’s largest companies in the industry.
MTS Health Investors makes equity investments in companies that operate within the services sectors of the healthcare industry. The firm focuses on companies with profitable business models and a demonstrated ability to deliver cost-effective solutions. MTS manages more than $700 million in investments and is currently investing out of its fourth fund. The firm is based in New York City and invests in companies throughout the United States.
Petsky Prunier, with a team led by Christopher French and Anil Kuruganti, served as exclusive financial advisor to Medical Knowledge Group.
“When we commenced this process, we were looking for a partner with extensive healthcare knowledge and a strong network of relationships. Through its domain expertise and comprehensive coverage of our space, Petsky Prunier was essential in helping us find MTS, the ideal partner.” Leon Behar, CEO, Medical Knowledge Group
About Petsky Prunier LLC
Petsky Prunier is one of the leading investment banks to the technology, media, marketing, information, eCommerce, and healthcare industries. Our firm's merger and acquisition and private placement advisory services reflect a unique blend of product specialization and industry expertise. Together with strategic consulting firm Winterberry Group, a Petsky Prunier company, our organization represents one of the largest industry-specific advisors providing strategic and transactional services. We offer global reach supplemented through our partnerships in China and India. Securities transactions are processed through Petsky Prunier Securities LLC, a member of FINRA, and an affiliated entity. For more information, visit www.petskyprunier.com.
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...